INO
Inovio Pharmaceuticals Inc
Price:  
1.39 
USD
Volume:  
2,583,907.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO EV/EBITDA

-2826.5%
Upside

As of 2025-07-11, the EV/EBITDA ratio of Inovio Pharmaceuticals Inc (INO) is -0.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INO's latest enterprise value is 45.75 mil USD. INO's TTM EBITDA according to its financial statements is -105.00 mil USD. Dividing these 2 quantities gives us the above INO EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.8x - 17.2x 14.3x
Forward P/E multiples 26.4x - 34.8x 31.0x
Fair Price (44.33) - (28.72) (37.90)
Upside -3289.2% - -2166.5% -2826.5%
1.39 USD
Stock Price
(37.90) USD
Fair Price

INO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-07-10 -0.44
2025-07-09 -0.47
2025-07-08 -0.41
2025-07-07 -0.40
2025-07-03 -0.40
2025-07-02 -0.88
2025-07-01 -0.82
2025-06-30 -0.81
2025-06-27 -0.86
2025-06-26 -0.94
2025-06-25 -0.92
2025-06-24 -0.83
2025-06-23 -0.75
2025-06-20 -0.77
2025-06-18 -0.76
2025-06-17 -0.74
2025-06-16 -0.79
2025-06-13 -0.79
2025-06-12 -0.84
2025-06-11 -0.86
2025-06-10 -0.94
2025-06-09 -0.92
2025-06-06 -0.95
2025-06-05 -0.86
2025-06-04 -0.89
2025-06-03 -0.86
2025-06-02 -0.85
2025-05-30 -0.79
2025-05-29 -0.87
2025-05-28 -0.79
2025-05-27 -0.79
2025-05-23 -0.78
2025-05-22 -0.81
2025-05-21 -0.78
2025-05-20 -0.87
2025-05-19 -0.83
2025-05-16 -0.82
2025-05-15 -0.76
2025-05-14 -0.72
2025-05-13 -0.75
2025-05-12 -0.76
2025-05-09 -0.68
2025-05-08 -0.69
2025-05-07 -0.65
2025-05-06 -0.62
2025-05-05 -0.71
2025-05-02 -0.75
2025-05-01 -0.73
2025-04-30 -0.76
2025-04-29 -0.74